Caitlin Conner describes the benefits of X39 and X49 at Lifewave Conference
Article in International Journal of Healing LifeWave X39 Pilot Demonstrates Light Triggered Changes
Dr. Melinda H . Connor
https://www.academia.edu/76270649/LifeWave_X39_Pilot_Demonstrates_Light_Triggered_Changes?email_work_card=view-paper
Dr. Melinda H. Connor – Dr Caitlin A. Connor, LifeWave X39 and X49 TRIALS RESULTS.
Dr. Melinda H. Connor – Scientist of the Year 2020. Dr Connor was Guest Speaker at our LifeWave Nova 2021 online conference and has undertaken and been responsible for several of the LifeWave Research projects. Her completed work can be found under Science on the lifewave.com website. Melinda H. Connor holds degrees from Harvard University, Wellesley College, University of San Francisco, American Military University, California Coast University and University of Arizona. Dr. Connor was a National Institutes of Health T-32 post-doctoral fellow and received her training as a research scientist at the University of Arizona in the Program in Integrative Medicine under Dr. Andrew Weil and Dr. Iris Bell. She is the former director of the Optimal Healing Research Program at the Laboratory for Advances in Consciousness and Health at the University of Arizona, directed by Dr. Gary E. Schwartz. A professor with appointments at multiple universities, Dr. Connor is board certified and a fellow of the American Alternative Medicine Association. Dr. Connor is the founder of EarthSongs Holistic Consulting which does research and consulting. She is the author of 10 books.. On Jan 6, 2020 Dr. Connor was awarded the “Scientist of the Year” at the 20th World Congress on Qigong and was given the honor of receive recognition by the CA State Legislature for her work.
DR Caitlin A. Connor, MAcOM, DAOM, EHP-C
Dr. Caitlin Connor, has completed her post-doctoral diploma in Health Sciences Research at the University of Oxford, UK. What is NTx The N-terminal telopeptide (NTX), also known as amino-terminal collagen crosslinks, is the N-terminal telopeptide of fibrillar collagens such as collagen type I and type II. It is used as a biomarker to measure the rate of bone turnover. NTX can be measured in the urine (uNTX) or serum (serum NTX). The Osteoporosis Risk Assessment (NTx) is a urine test which measures the risk of osteoporosis by detecting the rate of bone resorption (breakdown) well before significant changes are obvious on bone mineral density scans.
FAST FACTS ON X39 PILOT STUDY
X39 Pilot study by Dr. Melinda H. Connor
THE METABOLISM PILOT STUDY
• 17 Amino acid changes at significance at the end of the week.
• Produced anti-inflammatory effects based on amino acid results.
• A reduction in blood pressure at significance.
• Improves quality of sleep.
• Increased vitality.
• Improved short term memory.
THE METABOLISM DOUBLE BLIND PILOT STUDY
• Increase in 8 amino acids at significant levels over the 3 time periods.
• Increase in 3 amino acids at near significance.
• Improved short term memory at significant levels over 7 days.
• Improved mid term memory at near significance in 7 days.
• Improved quality of sleep at significant levels within 24 hours.
• Increase in Vitality at near significant levels in 7 days.
• Reduction in blood pressure at significance in 7 days.
• Improved muscle relaxation at near significance in 7 days.
• Improved Heart Rate Variability at significance in 7 days.
• Increase in depth of respiration at near significance in 7 days. (Breathing more deeply.)
THE BLOOD PLASMA PILOT STUDY
• Increased production at significance of GHK in 24 hours.
• Increased production at significance of GHK-Cu in 7 days.
+++++++++++++++++++++++++++++++++
Other more comprehensive long term studies are now on its way to back up these impressive finding.
Dr. Melinda H. Connor lIfeWave X39 and X49 TRIALS RESULTS
What is NTx The N-terminal telopeptide (NTX), also known as amino-terminal collagen crossl
Promoting HEALTH | WELLNESS 